Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular
edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage
versus a low dosage.